… ) group published the first case series of rituximab-related PML [41]. … of rituximab therapy,
with current incidence rates estimation ranging from 0.2 to 2.56 per 10,000 exposed patients [42…

… issues associated with PML infection developing after rituximab treatment. Since the first
case series report of 52 cases of rituximab-associated PML among patients with non-Hodgkin …

… era, PML was an opportunistic infection almost exclusively diagnosed in AIDS patients.
PML in HIV-negative patients was driven from rarity to clinical mainstream thanks to iatrogenic …

… rituximab has also been associated with PML. However, the relative risk for the development
of PML in patients with rituximab treatment for … medication in HIV-negative patients 62. In …

… risk of PML are patients with hematological malignancies mostly previously treated with
immunotherapies but also untreated, patients with HIV infection, and patients using monoclonal …

… of patients being treated with various monoclonal antibodies, such as natalizumab and
rituximab … 58% for HIV-negative PML patients [20]. In HIV-related PML, highly active antiretroviral …

… Six patients received immunosuppressive therapy in the year … therapy in 3 cases, rituximab
in 5 cases, anti-TNF-α therapy, … but 1 patient died after a median of 8 months following PML …

… fossa PML while on rituximab. She … rituximab were reported in the literature, our case
describes a rare type of PML affecting the posterior fossa in an HIV-negative patient on rituximab…

… This retrospective analysis included 47 patients with high tumour burden FL (… rituximab
maintenance following six cycles of BR induction chemotherapy. All patients were HIV-negative. …

… polyoma virus named after the patient from whom it was first … natalizumab, efalizumab, and
rituximab. Diagnosis of PML is … -IRIS were performed in HIV-negative patients, there is some …